The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Role of Lipoprotein(a) and Apolipoprotein(a) Phenotype in Atherogenesis: Prospective Results From the Bruneck Study
Abstract
Background —Experimental studies have suggested both atherogenic and thrombogenic properties of lipoprotein(a) [Lp(a)], depending on Lp(a) plasma concentrations and varying antifibrinolytic capacity of apolipoprotein(a) [apo(a)] isoforms. Epidemiological studies may contribute to assessment of the relevance of these findings in the general population. Methods and Results —This study prospectively investigated the association between Lp(a) plasma concentrations, apo(a) phenotypes, and the 5-year progression of carotid atherosclerosis assessed by high-resolution duplex ultrasound in a random sample population of 826 individuals. We differentiated early atherogenesis (incident nonstenotic atherosclerosis) from advanced (stenotic) stages in atherosclerosis that originate mainly from atherothrombotic mechanisms. Lp(a) plasma concentrations predicted the risk of early atherogenesis in a dose-dependent fashion, with this association being confined to subjects with LDL cholesterol levels above the population median (3.3 mmol/L). Apo(a) phenotypes were distributed similarly in subjects with and without early carotid atherosclerosis. In contrast, apo(a) phenotypes of low molecular weight emerged as one of the strongest risk predictors of advanced stenotic atherosclerosis, especially when associated with high Lp(a) plasma concentrations (odds ratio, 6.4; 95% CI, 2.8 to 14.9). Conclusions —Lp(a) is one of the few risk factors capable of promoting both early and advanced stages of atherogenesis. Lp(a) plasma concentrations predicted the risk of early atherogenesis synergistically with high LDL cholesterol. Low-molecular-weight apo(a) phenotypes with a putatively high antifibrinolytic capacity in turn emerged as one of the leading risk conditions of advanced stenotic stages of atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
cDNA sequence of human apolipoprotein(a) is homologous to plasminogen
McLean, J. W., Tomlinson, J. E., Kuang, W.-J., Eaton, D. L., Chen, E. Y., Fless, G. M., Scanu, A. M., & Lawn, R. M. (1987) · Nature · doi:10.1038/330132a0 · Cited by 1,886
Hajjar, K. A., Gavishi, D., Breslow, J. L., & Nachman, R. L. (1989) · Nature · doi:10.1038/339303a0 · Cited by 702
Armstrong, V. W., Cremer, P., Eberle, E., Manke, A., Schulze, F., Wieland, H., Kreuzer, H., & Seidel, D. (1986) · Atherosclerosis · doi:10.1016/0021-9150(86)90099-7 · Cited by 626
A potential basis for the thrombotic risks associated with lipoprotein(a)
Miles, L. A., Fless, G. M., Levin, E. G., Scanu, A. M., & Plow, E. F. (1989) · Nature · doi:10.1038/339301a0 · Cited by 583
O'Leary, D. H., Polak, J. F., Wolfson, S. K., Bond, M. G., Bommer, W., Sheth, S., Psaty, B. M., Sharrett, A. R., & Manolio, T. A. (1991) · Stroke · doi:10.1161/01.str.22.9.1155 · Cited by 504
Lipoprotein(a), fibrin binding, and plasminogen activation.
Loscalzo, J., Weinfeld, M., Fless, G. M., & Scanu, A. M. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.2.240 · Cited by 461
The National Survey of Stroke. Clinical findings.
Walker, A., Robins, M., & Weinfeld, F. D. (1981) · PubMed · Cited by 460
Ultrasonic evaluation of early carotid atherosclerosis.
Handa, N., Matsumoto, M., Maeda, H., Hougaku, H., Ogawa, S., Fukunaga, R., Yoneda, S., Kimura, K., & Kamada, T. (1990) · Stroke · doi:10.1161/01.str.21.11.1567 · Cited by 416
Proliferation of Human Smooth Muscle Cells Promoted by Lipoprotein(a)
Grainger, D. J., Kirschenlohr, H. L., Metcalfe, J. C., Weissberg, P. L., Wade, D. P., & Lawn, R. M. (1993) · Science · doi:10.1126/science.8503012 · Cited by 408
Grainger, D. J., Kemp, P. R., Metcalfe, J. C., Liu, A. C., Lawn, R. M., Williams, N. R., Grace, A. A., Schofield, P. M., & Chauhan, A. (1995) · Nature Medicine · doi:10.1038/nm0195-74 · Cited by 378
Marcovina, S. M., Albers, J. J., Gabel, B., Koschinsky, M. L., & Gaur, V. P. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.2.246 · Cited by 354
Apo(a) isoforms predict risk for coronary heart disease. A study in six populations.
Sandholzer, C., Saha, N., Kark, J. D., Rees, A., Jaross, W., Dieplinger, H., Hoppichler, F., Boerwinkle, E., & Utermann, G. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.10.1214 · Cited by 352
Self-citationActivation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice
Grainger, D. J., Kemp, P. R., Liu, A. C., Lawn, R. M., & Metcalfe, J. C. (1994) · Nature · doi:10.1038/370460a0 · Cited by 352
Etingin, O. R., Hajjar, D. P., Hajjar, K. A., Harpel, P. C., & Nachman, R. L. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52266-3 · Cited by 317
Ultrasonic evaluation of early carotid atherosclerosis.
NHanda, MMatsumoto, HMaeda, HHougaku, SOgawa, RFukunaga, SYoneda, KKimura, & TKamada (1990) · Stroke · Cited by 309
Effects of Lowering Elevated LDL Cholesterol on the Cardiovascular Risk of Lipoprotein(a)
Maher, V. M. G. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530220037029 · Cited by 298
Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin.
Harpel, P. C., Gordon, B. R., & Parker, T. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3847 · Cited by 285
Expressed hypervariable polymorphism of apolipoprotein (a).
Kamboh, M. I., Ferrell, R. E., & Ba, K. (1991) · PubMed · Cited by 215
The Natural Course of Atherosclerosis: Part II: Vascular Remodeling
Kiechl, S., & Willeit, J. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.6.1491 · Cited by 207
Self-citationWild, S. H., Fortmann, S. P., & Marcovina, S. M. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.2.239 · Cited by 194
The Natural Course of Atherosclerosis: Part I: Incidence and Progression
Kiechl, S., & Willeit, J. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.6.1484 · Cited by 186
Self-citationCoronary atherosclerosis. A multifactorial disease.
Jj, B., Fuster, V., Chesebro, J. H., & Badimón, L. (1993) · PubMed · Cited by 184
Willeit, J., & Kiechl, S. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.5.661 · Cited by 176
Self-citationCrouse, J. R., Harpold, G. J., Kahl, F. R., Toole, J. F., & McKinney, W. M. (1986) · Stroke · doi:10.1161/01.str.17.2.270 · Cited by 157
Kronenberg, F., Neyer, U., Lhotta, K., Trenkwalder, E., Auinger, M., Pribasnig, A., Meisl, T., König, P., & Dieplinger, H. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1051027 · Cited by 155
Self-citationApolipoprotein(a) Induces Monocyte Chemotactic Activity in Human Vascular Endothelial Cells
Poon, M., Zhang, X., Dunsky, K. G., Taubman, M. B., & Harpel, P. C. (1997) · Circulation · doi:10.1161/01.cir.96.8.2514 · Cited by 131
Takami, S., Yamashita, S., Kihara, S., Ishigami, M., Takemura, K., Kume, N., Kita, T., & Matsuzawa, Y. (1998) · Circulation · doi:10.1161/01.cir.97.8.721 · Cited by 126
Pillarisetti, S., Paka, L., Obunike, J. C., Berglund, L., & Goldberg, I. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119602 · Cited by 112
Lipoprotein(a) inhibition of plasminogen activation by tissue-type plasminogen activator
Edelberg, J. M., Gonzalez–Gronow, M., & Pizzo, S. V. (1990) · Thrombosis Research · doi:10.1016/0049-3848(90)90203-o · Cited by 111
Kronenberg, F., Kathrein, H., König, P., Neyer, U., Sturm, W., Lhotta, K., Gröchenig, E., Utermann, G., & Dieplinger, H. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.9.1405 · Cited by 102
Self-citationLipoprotein(a) in Health and Disease
Kronenberg, F., Steinmetz, A., Kostner, G. M., & Dieplinger, H. (1996) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369609080056 · Cited by 101
Self-citationHopkins, P. N., Wu, L., Hunt, S. C., James, B. C., Vincent, G. M., & Williams, R. R. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.2783 · Cited by 99
Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?
Hervio, L., Chapman, M. J., Thillet, J., et al. (1993) · Blood · doi:10.1182/blood.v82.2.392.392 · Cited by 98
LIPOPROTEIN(α) IN HEALTH AND DISEASE
Byrne, C. D., & Wild, S. H. (1994) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1994.tb09808.x · Cited by 93
Willeit, J., Kiechl, S. J., Santer, P., Oberhollenzer, F., Egger, G., Jarosch, E., & Mair, A. (1995) · Stroke · doi:10.1161/01.str.26.9.1582 · Cited by 80
Self-citationApolipoprotein(a) isoforms and coronary heart disease in men
Klausen, I. C., Sjøl, A., HANSEN, P. S., Gerdes, L. U., Møller, L. F., Lemming, L., Schroll, M., & Færgeman, O. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00071-3 · Cited by 77
Brown, S. A., Morrisett, J. D., Boerwinkle, E., Hutchinson, R. G., & Patsch, W. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.11.1558 · Cited by 77
Lipoprotein(a) Is a Potent Chemoattractant for Human Peripheral Monocytes
Syrovets, T., Thillet, J., Chapman, M. J., & Simmet, T. (1997) · Blood · doi:10.1182/blood.v90.5.2027 · Cited by 69
Kraft, H. G., Lingenhel, A., Bader, G., Kostner, G. M., & Utermann, G. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05844-3 · Cited by 47
Self-citationHervio, L., Girard-Globa, A., Durlach, V., & Anglés‐Cano, E. (1996) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1996.156288.x · Cited by 39
Leerink, C. B., Duif, P. F. C. C. M., Verhoeven‐Duif, N. M., Hackeng, C. M., Leus, F. R., Prins, J., Bouma, B. N., & van Rijn, H. J. M. (1994) · Fibrinolysis and Proteolysis · doi:10.1016/0268-9499(94)90046-9 · Cited by 21
Cited by
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Lipoprotein(a) as a cardiovascular risk factor: current status
Nordestgaard, B. G., Chapman, M. J., Ray, K., Borén, J., Andreotti, F., Watts, G. F., Ginsberg, H., Amarenco, P., Catapano, A., Descamps, O. S., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq386 · Cited by 1,807
(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753
Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Clarke, R., Peden, J. F., Hopewell, J. C., Kyriakou, T., Goel, A., Heath, S. C., Parish, S., Barlera, S., Franzosi, M. G., Rust, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902604 · Cited by 1,671
Kronenberg, F., Mora, S., Stroes, E. S. G., Ference, B. A., Arsenault, B. J., Berglund, L., Dweck, M. R., Koschinsky, M., Lambert, G., Mach, F., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac361 · Cited by 1,449
Self-citation
Metadata
- Authors
- Kronenberg, F., Kronenberg, M. F., Kiechl, S., Trenkwalder, E., Santer, P., Oberhollenzer, F., Egger, G., Utermann, G., & Willeit, J.
- Venue
- Circulation
- Published
- 1999-09-14
- Volume
- 100
- Issue
- 11
- Pages
- 1154-1160
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2160182135
- Cited by
- 293
- References
- 42
- FWCI
- 14.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.